Pages that link to "Q35044663"

The following pages link to Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems (Q35044663):

Displaying 44 items.

• Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells. (Q24630453) (← links)
• Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome (Q26775847) (← links)
• Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease (Q28482356) (← links)
• Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds (Q28482428) (← links)
• Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α (Q28568120) (← links)
• The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations (Q31122398) (← links)
• Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs (Q34186505) (← links)
• Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats (Q34476283) (← links)
• Proinflammatory Stimuli ControlN-Acylphosphatidylethanolamine-Specific Phospholipase D Expression in Macrophages (Q34715657) (← links)
• Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner (Q36027964) (← links)
• Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. (Q36329468) (← links)
• Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (Q36348374) (← links)
• Evaluation of fatty acid amides in the carrageenan-induced paw edema model (Q36384547) (← links)
• Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain (Q36912778) (← links)
• Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation (Q37382150) (← links)
• Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion. (Q37595794) (← links)
• Fatty acid amide signaling molecules (Q37785382) (← links)
• Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator (Q38118187) (← links)
• Mast cells, glia and neuroinflammation: partners in crime? (Q38137173) (← links)
• Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. (Q38157791) (← links)
• N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis (Q38599291) (← links)
• A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models (Q38646217) (← links)
• The anti-inflammatory compound palmitoylethanolamide inhibits prostaglandin and hydroxyeicosatetraenoic acid production by a macrophage cell line (Q38709659) (← links)
• Randomized split-mouth study on postoperative effects of palmitoylethanolamide for impacted lower third molar surgery (Q38807985) (← links)
• Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study. (Q38904448) (← links)
• Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients (Q38908402) (← links)
• Effect of acute administration of Pistacia lentiscus L. essential oil on rat cerebral cortex following transient bilateral common carotid artery occlusion (Q41868953) (← links)
• 2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation (Q42239212) (← links)
• Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice (Q42474130) (← links)
• Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice (Q42713290) (← links)
• Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. (Q44764531) (← links)
• Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase (Q46190650) (← links)
• Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion (Q48103877) (← links)
• Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion. (Q48133937) (← links)
• Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects (Q48139053) (← links)
• Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence. (Q52632555) (← links)
• Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice (Q58331887) (← links)
• Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review (Q60918045) (← links)
• Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor Mice Improves Indices of Cardiometabolic Disease (Q61445127) (← links)
• [Topical treatment of skin aging] (Q81484040) (← links)
• The Effect of Orally Dosed Levagen+™ (palmitoylethanolamide) on Exercise Recovery in Healthy Males-A Double-Blind, Randomized, Placebo-Controlled Study (Q89920458) (← links)
• Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets (Q90079410) (← links)
• N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway (Q90383058) (← links)
• Efficacy of a Combination of N-Palmitoylethanolamide, Beta-Caryophyllene, Carnosic Acid, and Myrrh Extract on Chronic Neuropathic Pain: A Preclinical Study (Q91970792) (← links)